Does RITLECITINIB Cause Off label use? 82 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Off label use have been filed in association with RITLECITINIB (Litfulo). This represents 5.7% of all adverse event reports for RITLECITINIB.
82
Reports of Off label use with RITLECITINIB
5.7%
of all RITLECITINIB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Off label use From RITLECITINIB?
Of the 82 reports, 2 (2.4%) required hospitalization, and 1 (1.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITLECITINIB. However, 82 reports have been filed with the FAERS database.
What Other Side Effects Does RITLECITINIB Cause?
Drug ineffective (259)
Therapeutic product effect incomplete (122)
Condition aggravated (85)
Headache (70)
Diarrhoea (49)
Product dose omission issue (45)
Alopecia (44)
Fatigue (36)
Urticaria (36)
Acne (35)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which RITLECITINIB Alternatives Have Lower Off label use Risk?
RITLECITINIB vs RITODRINE
RITLECITINIB vs RITONAVIR
RITLECITINIB vs RITUXAN
RITLECITINIB vs RITUXIMAB
RITLECITINIB vs RITUXIMAB-ABBS